NASDAQ:CTMX
CytomX Therapeutics Stock News
$1.60
-0.0300 (-1.84%)
At Close: Apr 25, 2024
CytomX Therapeutics Announces Full Exercise of Underwriters' Option to Purchase Additional Shares
08:00am, Wednesday, 03'rd Feb 2021
SOUTH SAN FRANCISCO, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage, oncology-focused biopharmaceutical company with a vision of transforming live
Steven Cohen Snaps Up Stake in CytomX Therapeutics
12:43pm, Wednesday, 27'th Jan 2021
Point72 Asset Management leader Steven Cohen (Trades, Portfolio) disclosed earlier this week his firm entered an 8.9% stake in CytomX Therapeutics Inc. (NASDAQ:CTMX).
Why Editas Medicine, Inovio, Dyne, and CytomX Stocks Are Falling Today
12:00pm, Thursday, 21'st Jan 2021
All four biotechs announced the pricing of stock offerings.
CytomX Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock
09:50pm, Wednesday, 20'th Jan 2021
SOUTH SAN FRANCISCO, Calif., Jan. 20, 2021 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage, oncology-focused biopharmaceutical company with a vision of transforming live
CytomX Therapeutics Announces Proposed Public Offering of Common Stock
04:35pm, Tuesday, 19'th Jan 2021
SOUTH SAN FRANCISCO, Calif., Jan. 19, 2021 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage, oncology-focused biopharmaceutical company with a vision of transforming lives
CytomX Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
08:00am, Thursday, 07'th Jan 2021
SOUTH SAN FRANCISCO, Calif., Jan. 07, 2021 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investi
CytomX Therapeutics Appoints Dr. Mani Mohindru to Board of Directors
04:05pm, Tuesday, 22'nd Dec 2020
SOUTH SAN FRANCISCO, Calif., Dec. 22, 2020 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investi
CytomX Therapeutics to Present at Upcoming Investor Conferences
04:01pm, Wednesday, 11'th Nov 2020
SOUTH SAN FRANCISCO, Calif., Nov. 11, 2020 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investi
CytomX Therapeutics, Inc. (CTMX) CEO Sean McCarthy on Q3 2020 Results - Earnings Call Transcript
10:39pm, Saturday, 07'th Nov 2020
CytomX Therapeutics, Inc. (CTMX) CEO Sean McCarthy on Q3 2020 Results - Earnings Call Transcript
CytomX Therapeutics Announces Third Quarter 2020 Financial Results and Provides Business Update
04:15pm, Thursday, 05'th Nov 2020
Company to host a conference call today, November 5, 2020, at 5:00 p.m. ET / 2:00 p.m. PT Company to host a conference call today, November 5, 2020, at 5:00 p.m. ET / 2:00 p.m. PT
CytomX Therapeutics to Announce Third Quarter 2020 Financial Results
08:00am, Thursday, 29'th Oct 2020
-Teleconference Scheduled for November 5, 2020, at 5:00 p.m. ET / 2:00 p.m. PT- -Teleconference Scheduled for November 5, 2020, at 5:00 p.m. ET / 2:00 p.m. PT-
Credit Union tops Customer Experience rankings again
07:52am, Tuesday, 20'th Oct 2020
The key role which frontline staff play in helping companies to exceed customers' expectations during Covid-19 is one of the key themes to emerge in the latest annual survey of Irish brands based on c
4 Key Customer Experience Metrics Brands Should Be Tracking
12:00am, Tuesday, 01'st Sep 2020
As we continue to deal with the pandemic, companies have to continue to deliver great customer experience. This starts by utilizing data and tools that eliminate friction and keep customers satisfied
Schneider to Test Electric Trucks as Part of Freightliner’s Customer Experience (CX) Fleet
12:00am, Wednesday, 26'th Aug 2020
Schneider has been selected to participate in the all-electric Freightliner Customer Experience (CX) Fleet.
CytomX Therapeutics (CTMX) Presents At 2020 Wedbush PacGrow Healthcare Conference - Slideshow
06:02pm, Thursday, 13'th Aug 2020
The following slide deck was published by CytomX Therapeutics, Inc. in conjunction with this event..